Dr. Sacco on Upfront Treatments for Head and Neck Cancer
Assuntina G. Sacco, MD
Assuntina G. Sacco, MD, assistant professor of medicine, medical oncologist, UC San Diego Health, discusses upfront treatment for patients with head and neck cancer.
Data suggests that higher-dose cisplatin is superior to weekly-dose regarding local regional control. There is a trend to improved disease-free survival and overall survival, however further research is needed.
According to Sacco, trials have not shown a survival benefit with induction chemotherapy, therefore the use of induction chemotherapy should be limited to select patients.